Navigation Links
Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
Date:6/2/2010

with sunitinib or sorafenib. In the European Union (EU), Afinitor is approved for the treatment of patients with advanced RCC whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted therapy.

In the US, everolimus is available in different dosage strengths under the trade name Zortress® for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant. In the EU, everolimus is available in different dosage strengths under the trade name Certican® for the prevention of organ rejection in heart and kidney transplant recipients.

With once-daily dosing, everolimus works by targeting mTOR in cancer cells, a protein that acts as a central regulator of tumor cell division, blood vessel growth and cell metabolism.

As an investigational compound, the safety and efficacy profile of everolimus has not yet been established in NET. Access to everolimus for NET has been carefully controlled and monitored in clinical trials designed to better understand the potential benefits and risks of the compound. Because of the uncertainty of clinical trials, there is no guarantee that everolimus will become commercially available for NET anywhere in the world.

Afinitor (everolimus) tablets important safety information

Afinitor is contraindicated in patients with hypersensitivity to everolimus, to other rapamycin derivatives or to any of the excipients. Potentially serious adverse reactions to Afinitor include non-infectious pneumonitis and infections, for which patients should be monitored carefully and treated as needed. In addition, non-infectious pneumonitis may require temporary dose reduction and/or interruption or discontinuation. Patients with systemic invasive fungal infections should not receive Afinit
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Diabetes Care Devices ... Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing ... Forecast to 2020" report to their offering. ... to be valued at USD 1.7 Billion in 2015 ...
(Date:9/3/2015)... -- Omeros Corporation (NASDAQ: OMER ) today announced that ... Inc. and its subsidiary, Par Sterile Products, LLC, (collectively ... of New Jersey and in ... Delaware . The lawsuits were filed under ... patents, U.S. Patent Nos. 8,173,707, 8,586,633 and 9,066,856, which ...
(Date:9/3/2015)... 03, 2015 ... the addition of the "Investigation Report ... to their offering. Non-steroidal anti-inflammatory ... structure from steroids which have a similar ... analgestic and antipyretic effects with fewer side ...
Breaking Medicine Technology:The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Flurbiprofen Market Investigation Report 2010-2019 2
... Mo., Oct. 26 Boehringer Ingelheim, a global pharmaceutical ... business Boehringer Ingelheim Vetmedica, Inc., announced today that it ... significant portion of the Fort Dodge Animal Health business. ... Australia, Canada and South Africa, as well as two ...
... (CTI) (Nasdaq and MTA: CTIC) management will present at the 8th ... held October 28-29, 2009, at the Palace Hotel in San Francisco. ... Pacific Time. The conference will be webcast live with slides and ... at www.celltherapeutics.com . , , ...
Cached Medicine Technology:Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 2Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 3
(Date:9/3/2015)... , ... September 03, 2015 , ... ... disease in Haiti, has partnered with Slingshot® Product Development Group to manufacture a ... running water. Michael Wahl with DriButts plans to bring 600 DriButts Diapers to ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... applications are open for spring 2016. Scholarships are awarded two times each year ... The Warriors® is a national nonprofit dedicated to restoring a sense of self, ...
(Date:9/3/2015)... Ohio (PRWEB) , ... September 03, 2015 , ... ... ( http://www.tamarahartley.com ) announces the release of her debut book, “Stop Wasting Your ... Read a Book Day (September 6), Hartley’s guide to overcoming life’s obstacles by ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... disorder treatment for adults and adolescents struggling with anorexia, bulimia, binge eating ... the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu collaborates closely ...
(Date:9/3/2015)... IN (PRWEB) , ... September 03, 2015 , ... ... Care Act (ACA) triggering cost increases for fully insured employer-sponsored health insurance plans, ... large employers (1,000+ employees), according to data released from the 2014 United Benefit ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4
... the genomes of thousands of "never smokers" diagnosed with lung cancer ... say could be responsible for a significant number of those cancers. ... Lancet Oncology , the researchers reported that about 30 percent ... the same uncommon variant, or allele, residing in a gene known ...
... President Barack Obama is trying to lure anti-abortion Democrats to vote yes for the Senate health bill with promises that he will ... Youngstown Sheet & Tube Company v. Sawyer , 33 US 579 (1952). , ... ... ...
... ... Mom , ... 2010 -- This Mother’s Day, Save the Children has a special gift for your mom ... world. For as little as $13 you can buy, in your own mother’s name, one ...
... Michigan Leaders Urged to Increase Cigarette Tax by $1 , ... , , ... ... WASHINGTON , March 18 Kids in ...
... March 18 Bright Horizons Family Solutions ®, the world,s leading provider of employer-sponsored child care, early education, and work/life solutions, today announced that it has ... ... ... ...
... ARBOR, Mich. Nurses participating in shift work, ... increased risk of developing Irritable Bowel Syndrome (IBS) ... standard day-time schedule, according to research published in ... "We know that people participating in shift work ...
Cached Medicine News:Health News:Gene is linked to lung cancer development in never-smokers 2Health News:Gene is linked to lung cancer development in never-smokers 3Health News:Gene is linked to lung cancer development in never-smokers 4Health News:Betsy McCaughey Says Anti-Abortion Democrats Should not be Hoodwinked by President's Promise of Executive Order 'Fix' 2Health News:A Mother's Day Gift that Gives Lasting Joy 2Health News:Michigan Kids 'Kick Butts' on March 24 2Health News:Michigan Kids 'Kick Butts' on March 24 3Health News:Michigan Kids 'Kick Butts' on March 24 4Health News:Michigan Kids 'Kick Butts' on March 24 5Health News:Bright Horizons Honored as 'Company that Cares' for Third Straight Year 2Health News:Bright Horizons Honored as 'Company that Cares' for Third Straight Year 3Health News:Shift workers at more risk for irritable bowel syndrome, U-M study says 2
... The Titan™ Inflatable Penile Prosthesis ... designed to be surgically implanted ... management of erectile dysfunction (also ... provides the patient with voluntary ...
... The Alpha I continues to be ... show the Alpha I to have mechanical ... years on first-time implants. ioflex material contributes ... Alpha I. Thats because Bioflex: ,Provides maximum, ...
... AMS 700 Series is an advanced three-part inflatable ... abdomen, a pump placed in the scrotum and ... cavernosa. It closely simulates the look and performance ... innovative penile implant technology, the AMS 700 Series ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: